Skip to main content
COSM
NASDAQ Life Sciences

宇宙健康公司将于第二季度推出专利肝脏脂肪减少补充剂Liv18,瞄准数十亿美元市场

feedReported by Access Newswire
Sentiment info
Positive
Importance info
8
Price
$0.298
Mkt Cap
$11.159M
52W Low
$0.28
52W High
$1.32
Market data snapshot near publication time

summarizeSummary

宇宙健康公司宣布计划于2026年第二季度在美国推出Liv18,一种新型专利补充剂,用于减少肝脏脂肪。该产品由BergacynFF®驱动,在两个独立的随机对照试验中展示了临床疗效。对于一家微型上市公司来说,将临床证明和专利产品引入数十亿美元的美国肝脏健康市场,这代表着一个重大增长机会,因为它解决了影响超过30%成年人的病症。该公告是在4月1日最近的一项产品相关新闻之后,表明公司正在积极执行产品开发和扩张战略。投资者将关注第二季度推出和初期销售表现的细节。

在该公告发布时,COSM的交易价格为$0.30,交易所为NASDAQ,所属行业为Life Sciences,市值约为$1115.9万。 52周交易区间为$0.28至$1.32。 这则新闻被评估为积极市场情绪,重要性评分为8/10。 来源:Access Newswire。


show_chartPrice Chart

Share this article

Copied!

feed COSM - Latest Insights

COSM
Apr 24, 2026, 4:30 PM EDT
Filing Type: S-3/A
Importance Score:
9
COSM
Apr 20, 2026, 10:55 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 17, 2026, 2:00 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 15, 2026, 4:34 PM EDT
Filing Type: 10-K
Importance Score:
9
COSM
Apr 15, 2026, 9:25 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 13, 2026, 12:50 PM EDT
Source: Access Newswire
Importance Score:
7
COSM
Apr 10, 2026, 9:40 AM EDT
Source: Access Newswire
Importance Score:
9
COSM
Apr 08, 2026, 11:10 AM EDT
Source: Access Newswire
Importance Score:
8
COSM
Apr 01, 2026, 11:42 AM EDT
Source: Access Newswire
Importance Score:
7
COSM
Mar 19, 2026, 12:45 PM EDT
Source: GlobeNewswire
Importance Score:
9